Biotech · Public company · Watertown, MA, US
Kymera Therapeutics, Inc.
Ticker KYMR · SEC CIK 0001815442
Track this companyFree. Adds Kymera Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials134 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline10
- KT-621Phase 2 · Asthma (Diagnosis)ClinicalTrials.gov · fetched Nov 12, 2026
- KT-621Phase 2 · Eosinophilic AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- KT-621Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- KT-253Phase 1 · Myeloid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- KT-333Phase 1 · Non Hodgkin Lymphoma (NHL)ClinicalTrials.gov · fetched Nov 12, 2026
- KT-413Phase 1 · Non Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- KT-474Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- KT-579Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- KT-621Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- KT-621Phase 1 · Healthy Participants StudyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- A Study to Evaluate Different Oral Formulations of KT-621PHASE1 · RECRUITING · started Oct 5, 2026ClinicalTrials.gov NCT07823205 · fetched Nov 12, 2026
- A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma StudyPHASE2 · RECRUITING · started Jun 25, 2026ClinicalTrials.gov NCT07677059 · fetched Nov 12, 2026
- First-in-human Study of Orally Administered KT-579 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Feb 23, 2026ClinicalTrials.gov NCT07412288 · fetched Nov 12, 2026
- A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaPHASE2 · RECRUITING · started Jan 28, 2026ClinicalTrials.gov NCT07323654 · fetched Nov 12, 2026
- A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic DermatitisPHASE2 · ACTIVE_NOT_RECRUITING · started Nov 24, 2025ClinicalTrials.gov NCT07217015 · fetched Nov 12, 2026
- Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)PHASE1 · COMPLETED · started Apr 17, 2025ClinicalTrials.gov NCT06945458 · fetched Nov 12, 2026
- First-in-human Study of Orally Administered KT-621 in Healthy Adult ParticipantsPHASE1 · COMPLETED · started Oct 22, 2024ClinicalTrials.gov NCT06673667 · fetched Nov 12, 2026
- Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisPHASE2 · TERMINATED · started Nov 9, 2023ClinicalTrials.gov NCT06058156 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaPHASE2 · TERMINATED · started Sep 29, 2023ClinicalTrials.gov NCT06028230 · fetched Nov 12, 2026
- Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid TumorsPHASE1 · COMPLETED · started May 15, 2023ClinicalTrials.gov NCT05775406 · fetched Nov 12, 2026
- Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHLPHASE1 · COMPLETED · started Jun 13, 2022ClinicalTrials.gov NCT05233033 · fetched Nov 12, 2026
- Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid TumorsPHASE1 · COMPLETED · started May 19, 2022ClinicalTrials.gov NCT05225584 · fetched Nov 12, 2026
- A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)PHASE1 · COMPLETED · started Feb 23, 2021ClinicalTrials.gov NCT04772885 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 25, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 24, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026